After that, Lai and collaborators reported that a DNA aptamer against human PD-L1 blocked the binding between PD-1 and PD-L1, promoted lymphocyte proliferation in vitro, and suppressed tumor growth in vivo with minimum renal and liver toxicity. Here, CD274 is linked to neoplasm.